Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis-Reference-Cited by-同舟云学术

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis

Published:2020-01 Issue:1 Volume:158 Page:111-122.e10
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Hirano Ikuo^ORCID,Dellon Evan S.,Hamilton Jennifer D.,Collins Margaret H.,Peterson Kathryn^ORCID,Chehade Mirna,Schoepfer Alain M.,Safroneeva Ekaterina,Rothenberg Marc E.,Falk Gary W.,Assouline-Dayan Yehudith^ORCID,Zhao Qiong,Chen Zhen,Swanson Brian N.,Pirozzi Gianluca,Mannent Leda,Graham Neil M.H.,Akinlade Bolanle,Stahl Neil,Yancopoulos George D.,Radin Allen

Funder

Sanofi

Regeneron Pharmaceuticals,Inc

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference49 articles.

1. Eosinophilic esophagitis;Furuta;N Engl J Med,2015

2. Eosinophilic esophagitis: updated consensus recommendations for children and adults;Liacouras;J Allergy Clin Immunol,2011

4. Pathophysiology of eosinophilic esophagitis;O’Shea;Gastroenterology,2018

5. Molecular, genetic, and cellular bases for treating eosinophilic esophagitis;Rothenberg;Gastroenterology,2015

Cited by 301 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of dupilumab and risk factors for dupilumab-induced hypereosinophilia in severe asthma: a preliminary study from China;Annals of Medicine;2024-02-05

2. Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis;Clinical Gastroenterology and Hepatology;2024-02

3. The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs;International Journal of Molecular Sciences;2024-01-30

4. Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy;Allergy;2024-01-27

5. Mononuclear cell composition and activation in blood and mucosal tissue of eosinophilic esophagitis;Frontiers in Immunology;2024-01-22